Association between polymorphisms of FKBP5 gene and suicide attempt in a Mexican population: A case-control study

被引:9
作者
Hernandez-Diaz, Yazmin [1 ,2 ]
Beatriz Gonzalez-Castro, Thelma [1 ]
Alfonso Tovilla-Zarate, Carlos [3 ]
Esther Juarez-Rojop, Isela [1 ]
Lilia Lopez-Narvaez, Maria [4 ]
Perez-Hernandez, Nonanzit [5 ]
Manuel Rodriguez-Perez, Jose [5 ]
Delia Genis-Mendoza, Alma [6 ]
机构
[1] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Salud, Villahermosa, Tabasco, Mexico
[2] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Jalpa de Mendez, Jalpa De Mendez, Tabasco, Mexico
[3] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco, Tabasco, Mexico
[4] Secretaria Salud, Hosp Gen Yajalon, Yajalon, Chiapas, Mexico
[5] Inst Nacl Cardiol Ignacio Chavez, Dept Biol Mol, Ciudad De Mexico, Mexico
[6] Inst Nacl Med Genom, Lab Genom Enfermedades Psiquiatr & Neurodegenerat, Ciudad De Mexico, Mexico
关键词
Suicide attempt; Gene; Association; Polymorphism; Risk allele; CHILDHOOD TRAUMA; STRESS; EXPRESSION; VARIANTS; GENOTYPE; INCREASE; BEHAVIOR; RISK;
D O I
10.1016/j.brainresbull.2020.11.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Five polymorphisms (rs4713916, rs4713902, rs1360780, rs9296158 and rs3800373) of FKBP5 gene were analyzed in a case-control study comprising 423 Mexican individuals (146 individuals with suicide attempt and 277 controls). The SNP's were genotyped using the TaqMan-allelic assay. Genotype and allele frequencies were compared between the two groups, then the association between FKBP5 gene polymorphisms and suicide attempt was analyzed. We found a significant association of rs1360780 T minor allele (All, OR = 1.80, 95 % CI = 1.35-2.41, P = 0.0005; Males, OR = 2.25, 95 % CI = 1.44-3.50, P = 0.0002) as a suicide behavior risk factor. Conversely, rs3800373 C minor allele (All, OR = 0.61, 95 % CI = 0.46-0.83; P = 0.0013; Females, OR = 0.33, 95 % CI = 0.22-0.50; P = 0.0001) and the A-C-T-A-C haplotype (OR = 0.06, 95 % CI = 0.01-0.36; P = 0.002) were significantly associated as protective factors. No association was observed with the other SNP's. Our study suggests that SNP's in FKBP5 gene contribute to suicide behavior pathogenesis.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 36 条
[31]   Genetics of cortisol secretion and depressive symptoms: A candidate gene and genome wide association approach [J].
Velders, Fleur P. ;
Kuningas, Maris ;
Kumari, Meena ;
Dekker, Marieke J. ;
Uitterlinden, Andre G. ;
Kirschbaum, Clemens ;
Hek, Karin ;
Hofman, Albert ;
Verhulst, Frank C. ;
Kivimaki, Mika ;
Van Duijn, Cornelia M. ;
Walker, Brian R. ;
Tiemeier, Henning .
PSYCHONEUROENDOCRINOLOGY, 2011, 36 (07) :1053-1061
[32]   Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability [J].
Vermeer, H ;
Hendriks-Stegeman, BI ;
van der Burg, B ;
van Buul-Offers, SC ;
Jansen, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :277-284
[33]   The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoid-regulated genes, dependent on trauma exposure [J].
Yeo, S. ;
Enoch, M. -A. ;
Gorodetsky, E. ;
Akhtar, L. ;
Schuebel, K. ;
Roy, A. ;
Goldman, D. .
GENES BRAIN AND BEHAVIOR, 2017, 16 (02) :223-232
[34]   Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism [J].
Zannas, A. S. ;
Binder, E. B. .
GENES BRAIN AND BEHAVIOR, 2014, 13 (01) :25-37
[35]   Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications [J].
Zannas, Anthony S. ;
Wiechmann, Tobias ;
Gassen, Nils C. ;
Binder, Elisabeth B. .
NEUROPSYCHOPHARMACOLOGY, 2016, 41 (01) :261-274
[36]   DNA sequence variants of the FKBP5 gene are associated with unipolar depression [J].
Zobel, Astrid ;
Schuhmacher, Anna ;
Jessen, Frank ;
Hoefels, Susanne ;
von Widdern, Olrik ;
Metten, Martin ;
Pfeiffer, Ute ;
Hanses, Claudia ;
Becker, Tim ;
Rietschel, Marcella ;
Scheef, Lukas ;
Block, Wolfgang ;
Schild, Hans H. ;
Maier, Wolfgang ;
Schwab, Sibylle G. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (05) :649-660